[3]
Barry, B.W. Transdermal drug delivery.In: The science of dosage form Design; Aulton, M.E., Ed.; Churchill livingstone, Elsevier: Hungary, 2007, pp. 565-597.
[5]
Yasam, V.R.; Jawahar, N.; Jakki, S.L. Proniosomes: a novel nano vesicular transdermal drug delivery. J. Pharm. Sci. Res, 2013, 5(8), 153-158.
[6]
Singla, S.; Harikumar, S.L.; Aggarwal, G. Proniosomes for penetration enhancement in transdermal system. Int. J. Drug Dev. Res, 2012, 4(2), 1-13.
[13]
Chaw, C.S.; Ahkim, K.Y. Effect of formulation compositions on niosomal preparations. Pharm. Dev. echnol., 2013, 18, 667-72.
[15]
Frfkjaer, S.; Hjorth, E.; Wfrtis, O. Stability testing of liposomes during storage. In: Liposome technology; Gregoriadis, G., Ed.; CRC Press: Boca Raton (El), 1984, 1, pp. 235-245.
[21]
Singhrawat, A.; Kumar, M.S.; Khurana, B.; Mahadevan, N. Proniosomal gel: a novel topical delivery system. Int. J. A. P. R., 2011, 3, 1-10.
[22]
Vyas, S.P.; Khar, R.K. Niosomes: Targeted and Controlled Drug Delivery, 1st ed.;, 2002, pp. 249-279.
[23]
Sutturwar, P.M.; Fulzele, S.V.; Mande, V.S.; Khandare, J.N. Formulation and evaluation of Ketoconazole Niosomes. Indian J. Pharm., 2002, 64(2), 155-158.
[31]
Debnath, A.; Kumar, A. Structural and Functional significance of Niosome and Proniosome in Drug Delivery System. Int. J. pharm. Eng, 2015, 3(3), 621-637.
[34]
Indira, U.; Uma Shankar, M.S. Proniosomes as a Drug Carrier: A Review. Int. J. Pharm. Sci. Res., 2012, 3(12), 4617-4625.
[38]
Gupta, K.S.; Nappinnai, M.; Gupta, V.R.M. Formulation and evaluation of topical meloxicam niosomal gel. Int. J. Biopharm, 2010, 1, 1-13.
[39]
Youan, B.C.; Hussain, A.; Nguyen, N.T. Evaluation of sucrose esterases alternative surfactants in micro-encapsulation of proteins by the solvent evaporation method. AAPS PharmSciTech, 2003, 5(22)
[41]
Akhilesh, D.; Bini, K.B.; Kamath, J.V. Comparative study of carriers used in proniosomes. Int. J. Pharm. Chem. Sci, 2012, 3, 6-12.
[42]
Zografi, G.; Gennaro, A.R. Interfacial phenomena. Remington: The science and practice of pharmacy, 17th ed; Mark Publishing: Pennsylvania, 1995, pp. 241-251.
[47]
Khoee, S.; Yaghoobian, M. Niosomes: A novel approach in modern drug delivery systems. Nanostruct. Drug Deliv., 2017, 207-237.
[50]
Debnath, A.; Kumar, A. Structural and Functional significance of Niosome and Proniosome in Drug Delivery System. Inter. J. Pharm. Engin, 2015, 3(3), 621-637.
[52]
Yadav, K. Proniosomal Gel: A provesicular approach for transdermal drug delivery. Pharm. Lett., 2010, 2(4), 189-198.
[63]
Jeevana, J.B.; Guru, L.G. In-vitro and in-vivo evaluation of Transdermal prolonged release proniosomal gel formulations of Propranolol HCL. Int. J. Drug Dev. Res, 2014, 6(3), 7-17.
[65]
Mateti, A.; Habibuddin, M.; Jukanti, R. Proniosome based transdermal gels of valsartan: Formulation, in-vitro and ex-vivo characteRIZATION. IOSR J. Pharm. Biol. Sci., 2017, 12(5), 67-79.
[68]
Loona, S.; Gupta, N.B.; Khan, M.U. Preparation and characterization of metformin proniosomal gel for treatment of diabetes mellitus. Int. J. Pharm. Sci. Rev. Res., 2012, 15(2), 108-114.
[71]
Sagar, S.; Lavanya, S.; Sagar, V.; Nanjwade, B.K. Formulation and evaluation of proniosomal gel of capecitabine. Indo. Am. J. Pharm. Sci, 2017, 4(08), 2513-2520.
[73]
Sandeep, G.; Reddy, V.D.; Reddy, S.D. Formulation and evaluation of fluconazole pro-niosomal gel for topical administration. J. Appli. Pharm. Sci., 2014, 4(07), 098-104.
[74]
Benipal, G. Gobindpura; Payal, P.O. Design, development and evaluation of proniosomal gel of an antifungal drug - ketoconazole. Int. J. Pharm. Sci. Rev. Res., 2015, 31(2), 265-272.
[78]
Mateti, A.; Habibuddin, M.; Jadhav, S.; Gandu, S.; Devireddy, S.R. Formulation and evaluation of proniosome based drug delivery system of valcyclovir for in-vitro and ex-vivo performance analysis. J. Glob. Trends Pharm. Sci., 2017, 8(4), 4598-4607.
[79]
Nimbalwar, M.; Upadhye, K.; Dixit, G. Fabrication and evaluation of ritonavir proniosomal transdermal gel as a vesicular drug delivery system. Pharmacophore J., 2016, 7(2), 82-95.
[84]
Radha, G.V.; Chowdary, C.H.V. Formulation and evaluation of ornidazole proniosomal gel. Indo Ame. J. Pharm. Res., 2014, 4(06)
[87]
Shah, H.A.; Patel, D.R.; Sonpal, R.N.; Prajapati, P.A.; Patel, M.M. Formulation and comparative evaluation of transdermal patch and proniosomal gel of ropinirole, an anti-Parkinson’s drug. Int. J. Pharm. Sci. Nanotech., 2016, 9(1), 3092-3101.
[90]
Sarfaraz, M.D.; Vasantakumar, D.; Doddayya, H.; Goudannavar, P. Use of pronisome gel in antidepressant therapy: Design and evaluation. World J. Pharm. Res., 2014, 3(4), 642-656.
[91]
Thomas, L.; Jose, S.; George, S.J.; Vidya, V. Provesicular niosomes gel: A novel absorption modulator for transdermal delivery. Int. J. Drug Dev. Res, 2011, 3(3), 58-69.